Open- | Close- |
Vol / Avg.501.000 / 788.637K | Mkt Cap808.140M |
Day Range- - - | 52 Wk Range3.320 - 19.340 |
Cabaletta Bio Stock (NASDAQ: CABA) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.501.000 / 788.637K | Mkt Cap808.140M |
Day Range- - - | 52 Wk Range3.320 - 19.340 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.400 | -0.370 | 0.0300 | ||||
REV | 0 |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.440 | -0.370 | 0.0700 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-11-15 | Cantor Fitzgerald | Joshua Schimmer | Maintains | OverweightOverweight | Raises | 40.00 | 50.00 |
2023-11-10 | HC Wainwright & Co. | Douglas Tsao | Maintains | BuyBuy | Raises | 17.00 | 25.00 |
2023-11-08 | Morgan Stanley | Michael Ulz | Maintains | OverweightOverweight | Raises | 16.00 | 28.00 |
2023-10-24 | Cantor Fitzgerald | Joshua Schimmer | Initiates Coverage On | Overweight | Announces | - | 40.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
CABA | Cabaletta Bio | 0.86% | 808.1M |
VALN | Valneva | 7.5% | 865.3M |
ZNTL | Zentalis Pharma | 0% | 738.1M |
IMTX | Immatics | 0% | 704.3M |
PHAR | Pharming | -1.79% | 757.4M |
You can purchase shares of Cabaletta Bio (NASDAQ: CABA) through any online brokerage.
Other companies in Cabaletta Bio’s space includes: Valneva (NASDAQ:VALN), Zentalis Pharma (NASDAQ:ZNTL), Immatics (NASDAQ:IMTX), Pharming (NASDAQ:PHAR) and Tango Therapeutics (NASDAQ:TNGX).
The latest price target for Cabaletta Bio (NASDAQ: CABA) was reported by Cantor Fitzgerald on Wednesday, November 15, 2023. The analyst firm set a price target for 50.00 expecting CABA to rise to within 12 months (a possible 165.11% upside). 22 analyst firms have reported ratings in the last year.
The stock price for Cabaletta Bio (NASDAQ: CABA) is $18.86 last updated Today at November 28, 2023 at 12:49 PM UTC.
There is no dividend information for Cabaletta Bio.
Cabaletta Bio’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Cabaletta Bio.
Cabaletta Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.